肠促胰素类药物治疗非酒精性脂肪性肝病研究进展(3)
[6] Armstrong MJ，Gaunt P，Aithal GP，et al. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis(LEAN)：a multicentre，double-blind，randomised，placebo-controlled phase 2 study [J]. Lancet，2016，387(10019)：679-690.[7] Petit JM，Cercueil JP，Loffroy R，et al. Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes. The Lira-NAFLD study [J]. J Clin Endocrinol Metab ......
您现在查看是摘要页，全文长 2674 字符。